Stay updated on Phase 3 Study of CP-690,550 in Rheumatoid Arthritis Clinical Trial
Sign up to get notified when there's something new on the Phase 3 Study of CP-690,550 in Rheumatoid Arthritis Clinical Trial page.

Latest updates to the Phase 3 Study of CP-690,550 in Rheumatoid Arthritis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential temporary service limitations; previous version tag v3.1.0 was removed.SummaryDifference0.9%

- Check27 days agoChange DetectedRemoved several drug-safety/quality topics and added a new version tag (v3.1.0), indicating content restructuring and scope narrowing rather than new substantive content.SummaryDifference0.1%

- Check41 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2. The Back to Top element has been removed.SummaryDifference0.1%

- Check49 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.1%

- Check56 days agoChange DetectedThe webpage has undergone significant updates, including the addition of numerous specific locations for clinical studies related to Tofacitinib, as well as new drug information and related research topics. Notably, the total number of study locations has decreased from 117 to 115.SummaryDifference11%

- Check70 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%

Stay in the know with updates to Phase 3 Study of CP-690,550 in Rheumatoid Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 3 Study of CP-690,550 in Rheumatoid Arthritis Clinical Trial page.